Grade My Investments
HomeFree Stock Grades › CVRX

CVRx, Inc. (CVRX) Stock Grade

CVRX · Healthcare

B+
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$185.2M
P/E Ratio
Revenue Growth (YoY)
+10.5%
Net Margin
-94.1%
Return on Equity
Dividend Yield
None

About CVRx, Inc.'s fundamentals

CVRx is a small-cap medical device company with a market capitalization of $185.2 million that has achieved modest revenue growth of 10.5% year-over-year. However, the company is currently unprofitable, reporting a net loss in its latest annual statement with a net margin of -94.1%, meaning operating expenses significantly exceed revenue. The company does not pay a dividend, and traditional valuation metrics like P/E ratio and return on equity are not applicable due to the loss position. This profile is typical of early-stage medical device firms that are prioritizing growth and commercialization over profitability.

Track CVRX free — no credit card required. Live grade + monthly AI report →